Nyse:elv articles
-
Elevance Health (NYSE:ELV) Upgraded by Baird R W to Strong-Buy
Baird R W upgraded shares of Elevance Health (NYSE:ELV – Free Report) to a strong-buy rating in a research report released on Thursday, Zacks.com reports. A number of other equities research analysts have also weighed in on the company. Wells Fargo & Company boosted their target price on Elevance Health from $557.00 to $600.00 and […]
-
Beazer Homes USA (NYSE:BZH) and Smith Douglas Homes (NYSE:SDHC) Critical Review
Smith Douglas Homes (NYSE:SDHC – Get Free Report) and Beazer Homes USA (NYSE:BZH – Get Free Report) are both small-cap finance companies, but which is the better business? We will compare the two companies based on the strength of their valuation, earnings, institutional ownership, profitability, dividends, risk and analyst recommendations. Earnings & Valuation This table […]
-
Pfizer (NYSE:PFE) Trading Up 2%
Pfizer Inc. (NYSE:PFE – Get Free Report) shares were up 2% during trading on Wednesday . The company traded as high as $29.18 and last traded at $29.13. Approximately 8,421,879 shares changed hands during trading, a decline of 80% from the average daily volume of 42,146,465 shares. The stock had previously closed at $28.56. Analyst […]